Where Technology Meets Drug Development Reality
IndusQ is the bridge between breakthrough technology and breakthrough medicine. We help biopharma leaders achieve real R&D productivity gains. For small and mid-tier tech and AI innovators, we provide strategic partnership across the entire company lifecycle—from finding your first pharma customers to planning a successful exit.
Why We Exist
The Productivity Paradox
The life sciences industry invests over $200 billion annually in R&D. Yet, development timelines remain stubbornly long, and 90% of clinical trials still fail.
AI promises are everywhere, but results are hard to find. The problem isn't a lack of technology; it’s the gap between innovation and implementation. It’s the chasm between a powerful tool and its seamless adoption by the frontline R&D teams who drive progress.
How We Help Deep Tech
-
Finding Product-Market Fit & Creating Opportunity
The initial challenge is cutting through the noise. We help you refine your value proposition and create top-of-the-funnel opportunities by translating your technology into a clear solution for pharma’s most pressing R&D challenges. Our focus is on securing those critical first partnerships.
-
Accelerating Growth & Market Penetration
Once you have traction, the goal is to expand your footprint. We design and execute your go-to-market strategy, helping you build the right relationships and navigate complex sales cycles to accelerate growth and establish your solution as a trusted standard in the industry.
-
Realizing Value & Strategic Transition
A successful journey requires a well-planned destination. When the time is right, we provide strategic exit planning and transaction support. We leverage our deep industry knowledge and network to help you navigate diligence, position your company optimally, and realize the full value of what you've built.
Rewiring Your R&D
-
Establishing Your Digital & AI Baseline
Before you can build the future, you must understand the present. We begin with a comprehensive diagnostic of your current capabilities—assessing your people, processes, data ecosystems, and technology stack. We benchmark your operations against the industry to create a clear, data-driven picture of your starting point and identify the most significant gaps and opportunities.
-
Co-Creating Your Transformation Roadmap
With a clear baseline established, we co-create a pragmatic, multi-year AI and digital transformation roadmap. This is not just a technology plan; it's a strategic blueprint that prioritizes high-value use cases, outlines required capabilities, and defines a clear path for investment and execution. Our focus is on creating a realistic plan that aligns with your scientific goals and business objectives.
-
Implementing the New Operating Model
A roadmap is useless without execution. In this final stage, we help you build the new operating model to make your vision a reality. This involves embedding the right technologies into your workflows, fostering data and AI literacy across your teams, and establishing new governance and 'ways of working'. We focus on driving adoption and ensuring the transformation delivers sustainable, measurable improvements to your R&D productivity.
Our Approach
Advisors Who Have Been on Both Sides of the Table
Strategy to Execution: We've led enterprise transformations from conception to delivery. Our team brings deep subject-matter expertise and the scars that come from making change actually happen.
Pragmatically Visionary: We bridge the gap between ambitious goals and operational reality. We understand the urgency of a startup and the complex processes of a global pharma organization.
Value-Driven: Technology is only part of the solution. Transformation requires effective change management and building data & tech literacy across your R&D teams. We focus on ensuring your people actually adopt and succeed with new tools.
Results, Not Promises
We have been obsessed with one thing: bending the time and cost curve of drug development. This isn't theory. This is a track record of implemented solutions with measured outcomes.
Our Proof
50%
Cycle Time Reduction at a top-10 large biopharmaco
30%
Improvement in Study Start-Up at a top-20 biopharmaco
$100M+
In Run-Rate Savings Delivered
at CROs
5,000+
R&D Users Served by a Single Analytics Platform Built
at a top-20 biopharmaco
Our Core Expertise
While our experience spans the entire R&D value chain, our focus is sharp. We concentrate on the interconnected domains where we can drive the most significant, measurable improvements in productivity.
-
This is the engine room of biopharma. We dive deep into the mechanics of clinical development, from optimizing study start-up and trial design to enhancing patient enrollment and data management. Our goal is to make your clinical operations more predictable, efficient, and patient-centric.
-
We help you connect strategy to execution. A promising drug fails if the program is mismanaged. We implement robust frameworks for prioritizing projects, managing complex programs, and ensuring your entire portfolio is aligned with your most critical business objectives and financial realities.
-
Your most valuable asset is your people; your most finite is their time. We help you build data-driven models for resource management that align talent with your most important work. This isn't just about headcount; it's about deploying expertise with precision and foresight.
-
This is the connective tissue for everything we do. We help you move beyond AI hype by identifying and embedding the right technologies into your workflows. Our work is grounded in a relentless focus on user adoption and change management to ensure that innovation delivers on its promise.
IndusQ is led by founder Saurabh Awasthi, who brings 20 years of front-line experience in R&D transformation. He is supported by a dedicated team of seasoned life sciences and technology advisors who share his obsession with improving R&D productivity.
Together, we provide the cross-industry expertise needed to bridge the gap between brilliant innovation and meaningful adoption.
Who We Are